日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period

在6个月的评估期内,无症状或非重症SARS-CoV-2感染后中和抗体滴度较低。

Lazor-Blanchet, C; Zygoura, P; Dafni, U; Lamoth, F; Tsourti, Z; Lobritz, M A; Regina, J; Grandbastien, B; Fenwick, C; Pantaleo, G; Calandra, T; Meylan, S

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial

一项针对 HIV-1 感染者的初免加强免疫治疗策略的随机安慰剂对照疗效研究:VRI02 ANRS 149 LIGHT II 期试验

Lévy, Y; Lacabaratz, C; Lhomme, E; Wiedemann, A; Bauduin, C; Fenwick, C; Foucat, E; Surenaud, M; Guillaumat, L; Boilet, V; Rieux, V; Bouchaud, O; Girard, P-M; Molina, J-M; Morlat, P; Hocqueloux, L; Richert, L; Pantaleo, G; Lelièvre, J D; Thiébaut, R

Big Data Applications in Health Sciences and Epidemiology

大数据在健康科学和流行病学中的应用

Chaudhry, Imtiaz A; Shamsi, Farrukh A; Elzaridi, Elsanusi; Arat, Yonca O; Bosley, Thomas M; Riley, Fenwick C; Pyne, Saumyadipta; Vullikanti, Anile Kumar S; Marathe, Madhav V

Incidence and visual outcome of endophthalmitis associated with intraocular foreign bodies

眼内异物相关眼内炎的发生率和视力预后

Chaudhry, Imtiaz A; Shamsi, Farrukh A; Al-Harthi, Essam; Al-Theeb, Abdulwahab; Elzaridi, Elsanusi; Riley, Fenwick C